Barry Clemens

EKF Diagnostics

EKF Diagnostics is a global medical diagnostics business with specialisms in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. EKF is listed on the London Stock Exchange's AIM market. EKF's Point-of-Care heritage dates back to the development of glucose sensor technology in the 1990s. Since then our portfolio has broadened to include lactate, HbA1c and ketone testing. EKF Diagnostics is also a manufacturer of Central Laboratory products including Stanbio Chemistry reagents, benchtop analyzers, rapid tests and centrifuges. Our chemistry reagents can be used on the majority of analyzers found in hospital laboratories around the world. EKF Life Sciences has a long and successful reputation for delivering enzymes and contracted bio-products. The recently expanded production capacity at our manufacturing sites in the USA provides EKF Life Sciences with facilities to suit long-standing, high volume enzyme customers, as well as provide the flexibility needed for start-ups looking for tailored solutions.